Discordant temporal patterns of S100 β and cleaved tau protein elevation after head injury: a pilot study

There is considerable interest in S100 g protein as a potential marker that can be used to quantify central nervous system injury. However, increasing appreciation that S100 g may be produced by non-neural tissue (specifically adipocytes), has led to a search for more specific markers of brain injury. Recent interests have focused on a cleaved form of tau protein (c τ P) which is elevated in CSF from patients suffering traumatic brain injury. We have investigated whether levels in peripheral blood are a satisfactory alternative to provide an accessible marker of CNS injury severity. We measured levels of S100 g and c τ P in arterial blood from 20 patients with severe head injury. When compared with normal values S100 g was elevated 10-fold in the first 24 hours and c τ P was elevated at all time points, but showed a reversal of the temporal trend observed with S100 g. Patients with a poor outcome (GOS 1-3) had significantly higher S100 g levels on day one. Plasma c τ P levels did not correlate with outcome following head injury.

[1]  C. Heizmann Ca2+-Binding S100 Proteins in the Central Nervous System , 1999, Neurochemical Research.

[2]  L. Peris,et al.  Tau Protein Function in Axonal Formation , 2004, Neurochemical Research.

[3]  R. Anderson,et al.  The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. , 2000, The Annals of thoracic surgery.

[4]  The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Glasgow coma scale score. , 2000, Journal of neurotrauma.

[5]  The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Computed tomography scan features. , 2000, Journal of neurotrauma.

[6]  C. Alling,et al.  S100β after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome , 1999 .

[7]  V. Seifert,et al.  Fatal secondary increase in serum S-100B protein after severe head injury. Report of three cases. , 1999, Journal of neurosurgery.

[8]  R. Rudick,et al.  Quantification of Axonal Damage in Traumatic Brain Injury , 1999, Journal of neurochemistry.

[9]  G. Johnson,et al.  Tau protein in normal and Alzheimer's disease brain. , 1999, Journal of Alzheimer's disease : JAD.

[10]  G. Johnson,et al.  Tau protein in normal and Alzheimer's disease brain: an update. , 1999, Journal of Alzheimer's disease : JAD.

[11]  J. Pickard,et al.  Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[12]  C. Alling,et al.  Significance of serum S100 release after coronary artery bypass grafting. , 1998, The Annals of thoracic surgery.

[13]  C. Alling,et al.  The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. , 1997, Journal of cardiothoracic and vascular anesthesia.

[14]  D. Taggart,et al.  Comparison of Serum S-100β Levels During CABG and Intracardiac Operations , 1997 .

[15]  B. Romner,et al.  Management of minor head injury: the value of early computed tomography and serum protein S-100 measurements , 1997, Journal of Clinical Neuroscience.

[16]  D. Taggart,et al.  Comparison of serum S-100 beta levels during CABG and intracardiac operations. , 1997, The Annals of thoracic surgery.

[17]  C. Alling,et al.  Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. , 1996, The Annals of thoracic surgery.

[18]  J. van der Linden,et al.  Elevated serum levels of S-100 after deep hypothermic arrest correlate with duration of circulatory arrest. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  M. Mattson,et al.  S100β protects hippocampal neurons from damage induced by glucose deprivation , 1995, Brain Research.

[20]  M. Mattson,et al.  S100 beta protects hippocampal neurons from damage induced by glucose deprivation. , 1995, Brain research.

[21]  J L Tocher,et al.  Measuring the burden of secondary insults in head-injured patients during intensive care. , 1994, Journal of neurosurgical anesthesiology.

[22]  D. Hilt,et al.  The S100 protein family. , 1988, Trends in biochemical sciences.

[23]  P. Bucy,et al.  American Association of Neurological Surgeons , 1986 .

[24]  J. J. Buckley,et al.  Report of Three Cases , 1962 .